Privia Health ROA 2020-2025 | PRVA
Current and historical return on assets (ROA) values for Privia Health (PRVA) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Privia Health ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-09-30 | $0.02B | $1.35B | 1.46% |
| 2025-06-30 | $0.02B | $1.27B | 1.27% |
| 2025-03-31 | $0.02B | $1.18B | 1.32% |
| 2024-12-31 | $0.01B | $1.14B | 1.28% |
| 2024-09-30 | $0.01B | $1.15B | 1.22% |
| 2024-06-30 | $0.02B | $1.08B | 1.46% |
| 2024-03-31 | $0.02B | $1.03B | 1.92% |
| 2023-12-31 | $0.02B | $1.00B | 2.42% |
| 2023-09-30 | $0.04B | $0.99B | 4.22% |
| 2023-06-30 | $0.03B | $0.94B | 3.98% |
| 2023-03-31 | $0.02B | $0.88B | 2.11% |
| 2022-12-31 | $-0.01B | $0.79B | -1.04% |
| 2022-09-30 | $-0.04B | $0.81B | -5.13% |
| 2022-06-30 | $-0.05B | $0.75B | -7.04% |
| 2022-03-31 | $-0.21B | $0.72B | -32.15% |
| 2021-12-31 | $-0.19B | $0.69B | -33.41% |
| 2021-09-30 | $-0.17B | $0.63B | -36.31% |
| 2021-06-30 | $-0.15B | $0.60B | -46.15% |
| 2021-03-31 | $0.03B | $0.35B | 18.32% |
| 2020-12-31 | $0.03B | $0.33B | 37.69% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.684B | $1.736B |
| Privia Health Group Inc. is a technology-driven, physician enablement company which collaborates with medical groups, health plans and health systems to optimize physician practices, improve patient experiences and reward doctors for delivering high-value care in both in-person and virtual settings. Privia Health Group Inc. is based in Arlington, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $30.738B | 35.55 |
| Tempus AI (TEM) | United States | $9.941B | 0.00 |
| Doximity (DOCS) | United States | $5.129B | 21.79 |
| IRhythm Holdings (IRTC) | United States | $4.904B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $3.925B | 31.93 |
| Hinge Health (HNGE) | United States | $2.602B | 0.00 |
| 10x Genomics (TXG) | United States | $2.423B | 0.00 |
| Heartflow (HTFL) | United States | $2.325B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $1.980B | 32.76 |
| Omnicell (OMCL) | United States | $1.750B | 48.75 |
| Azenta (AZTA) | United States | $1.381B | 55.54 |
| Enovis (ENOV) | United States | $1.291B | 6.78 |
| Clover Health Investments (CLOV) | United States | $1.095B | 0.00 |
| Schrodinger (SDGR) | United States | $1.004B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.861B | 0.00 |
| Phreesia (PHR) | United States | $0.748B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.713B | 0.00 |
| Talkspace (TALK) | United States | $0.646B | 130.00 |
| Standard BioTools (LAB) | United States | $0.477B | 0.00 |
| Claritev (CTEV) | United States | $0.365B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.338B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.334B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.323B | 0.00 |
| Carlsmed (CARL) | United States | $0.320B | 0.00 |
| Evolent Health (EVH) | United States | $0.305B | 0.00 |
| TruBridge (TBRG) | United States | $0.285B | 13.10 |
| CapsoVision (CV) | United States | $0.220B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.216B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.212B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.171B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.158B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.146B | 0.00 |
| CareCloud (CCLD) | United States | $0.100B | 5.49 |
| Outset Medical (OM) | United States | $0.085B | 0.00 |
| American Well (AMWL) | United States | $0.072B | 0.00 |
| 111 (YI) | China | $0.069B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.067B | 0.00 |
| Pulmonx (LUNG) | United States | $0.060B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.046B | 0.00 |
| Precipio (PRPO) | United States | $0.037B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.028B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.025B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.016B | 0.00 |
| Movano (MOVE) | United States | $0.015B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.007B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| Zhongchao (ZCMD) | China | $0.006B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.006B | 0.00 |
| PROFUSA (PFSA) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |